How much has T-Therapeutics raised?

T-Therapeutics has raised $150M across 2 sourced rounds on record. The latest is $91M (Series A), announced November 13, 2025.

Who invested in T-Therapeutics?

Investors on record for T-Therapeutics: Business Growth Fund, Cambridge Enterprise Ventures, Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sanofi Ventures, Sofinnova Partners, Tencent and 1 other. Cambridge Innovation Capital led a round.

T-Therapeutics

Unleashing the power of natural T cells to reshape the clinical landscape for cancer patients

Health and bio

Latest funding

$91M Series A · November 13, 2025

Source: thepharmaletter.com

Total raised: $150M across 2 sourced rounds

All 2 rounds ↓

Website: t-therapeutics.com.

LinkedIn: t-therapeutics.

Category: Health and bio.

Stage: Series A.

Total raised: $150M in 2 sourced rounds.

Last round: Nov 13, 2025 · 344 days ago.

Headcount: 51–100 employees.

Domain age: 4 years.

On Recent Funding since: Oct 23, 2026.

About T-Therapeutics

Recent Funding lists T-Therapeutics under Health and bio. It raised $91M in a Series A round in November 2025, according to thepharmaletter.com. Recent Funding has 2 sourced rounds on record for it, totaling $150M, the first in November 2023. Investors on record include Business Growth Fund, Cambridge Enterprise Ventures, Cambridge Innovation Capital, Digitalis Ventures and 5 others.

TIMELINE · MONEY RAISED

T-Therapeutics | 568 days from website to first raise on record

Raised $150M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

November 13, 2025
Series A · $91M
BBusiness Growth Fund, CCambridge Enterprise Ventures, CCambridge Innovation Capital, DDigitalis Ventures, FF-Prime Capital, SSanofi Ventures, SSofinnova Partners, TTencent
Source: thepharmaletter.com
November 15, 2023
Series A · $59M
CCambridge Innovation Capital (lead), DDigitalis Ventures (lead), FF-Prime Capital (lead), SSofinnova Partners (lead), SSanofi Ventures, UUniversity of Cambridge Enterprise
Source: bioworld.com
April 26, 2022
Website created

Investors

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026

Other companies backed by Cambridge Innovation Capital

MMicrobiotica$47.69M Series B+ · Oct 2026
SSalience Labs$125M Series B+ · Oct 2026
CCMR Surgical$400M Series B+ · Oct 2026
TTRIMTECH Therapeutics$14M Seed · Jun 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
TTrent AI$13M Seed · Apr 2026

Cambridge Innovation Capital portfolio →

Questions and sources

T-Therapeutics: questions and answers

How much has T-Therapeutics raised?: T-Therapeutics has raised $150M across 2 sourced rounds on record. The latest is $91M (Series A), announced November 13, 2025.
Who invested in T-Therapeutics?: Investors on record for T-Therapeutics: Business Growth Fund, Cambridge Enterprise Ventures, Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sanofi Ventures, Sofinnova Partners, Tencent and 1 other. Cambridge Innovation Capital led a round.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/t-therapeutics (get a free API key).